NCT05199584 2026-03-05A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsEndeavor Biomedicines, Inc.Phase 2 Completed20 enrolled
NCT05139277 2026-02-06Evaluation of the CONVIVO SystemDartmouth-Hitchcock Medical CenterPhase NA Recruiting30 enrolled